Your session is about to expire
← Back to Search
Team-Based Connected Health (TCH) for Atopic Dermatitis (TCH in AD Trial)
N/A
Waitlist Available
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
TCH in AD Trial Summary
This trial will compare an online team-based model for managing atopic dermatitis to in-person care. It will measure disease severity, quality of life, access to care, and costs.
Eligible Conditions
- Atopic Dermatitis
TCH in AD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Disease
Secondary outcome measures
Change in access to care
Change in disease severity as measured by the Patient-Oriented Eczema Measure (POEM).
Change in disease severity as measured by the validated Investigator Global Assessment (vIGA)
+3 moreTCH in AD Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Team-Based Connected Health (TCH)Experimental Treatment1 Intervention
The intervention arm is the team-based connected health (TCH) model, which purports to increase access to specialists and improve outcomes. Specifically, TCH offers multiple modalities for patients and primary care providers (PCPs) to access dermatologists online directly and asynchronously. TCH also fosters team care and patient engagement through active sharing of management plans and multidirectional, informed communication among patients, PCPs, and dermatologists.
Group II: In-PersonActive Control1 Intervention
In-person care is the control group because it is currently considered the standard of care in delivering dermatologic services. The intervention includes regular visits to a physician, and may include such treatments as ointments, steroids or ultraviolet therapy at the discretion of a physician. In-person care is the major healthcare-delivery model for managing chronic skin diseases and a realistic, primary option that patients face. The patients in the in-person arm can seek atopic dermatitis care from primary care practitioners or dermatologists, just as they would in the real world.
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,595,978 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
484 Previous Clinical Trials
1,086,707 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining places in this experiment that somebody could join?
"Yes, this clinical trial is seeking volunteers at present. The listing on clinicaltrials.gov shows that the first posting was on August 27th, 2019 with the December 1st, 2020 update being the most recent."
Answered by AI
What is the total number of people taking part in this experiment?
"Yes, this is an active trial that was initially posted on 8/27/2019. To date, 300 patients have been enrolled from 1 site. The most recent update to the listing was on 12/1/2020."
Answered by AI
Who else is applying?
What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
University of Southern California
What portion of applicants met pre-screening criteria?
Met criteria
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger